Pages that link to "Q41429628"
Jump to navigation
Jump to search
The following pages link to Immunoadhesins as research tools and therapeutic agents (Q41429628):
Displaying 34 items.
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer (Q22008593) (← links)
- Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR (Q22009014) (← links)
- Emerging Vaccine Technologies (Q26783764) (← links)
- Anti-infective immunoadhesins from plants (Q26799080) (← links)
- Recombinant proteins for genetic disease. (Q33713530) (← links)
- Complement activation and inhibition in experimental models of arthritis (Q33852672) (← links)
- An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression (Q33900782) (← links)
- Protein targeting: altering receptor kinase function in the brain (Q33934220) (← links)
- Molecular therapeutics of liver disease (Q34269646) (← links)
- Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax (Q34483688) (← links)
- Pathway-specific engagement of ephrinA5-EphA4/EphA5 system of the substantia nigra pars reticulata in cocaine-induced responses (Q35049129) (← links)
- Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action (Q35087618) (← links)
- Discovery of small molecule leads in a biotechnology datastream (Q35160401) (← links)
- Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants (Q36004811) (← links)
- Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies (Q36602029) (← links)
- Engineering antibodies for imaging and therapy (Q36877861) (← links)
- Molecular decoys: antidotes, therapeutics and immunomodulators (Q37314633) (← links)
- Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches (Q37867011) (← links)
- Adeno-associated virus delivery of broadly neutralizing antibodies (Q38196689) (← links)
- Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc. (Q38934421) (← links)
- Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana (Q40395310) (← links)
- Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation (Q40842464) (← links)
- Expression of lymphotoxins and their receptor-Fc fusion proteins by baculovirus (Q40865797) (← links)
- Expression and characterization of a DNase I-Fc fusion enzyme (Q41616388) (← links)
- TRAF2 is a biologically important necroptosis suppressor (Q43170389) (← links)
- Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences (Q44652104) (← links)
- The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE. (Q48414222) (← links)
- Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. (Q51543749) (← links)
- Inhibition of foam cell formation using a soluble CD68-Fc fusion protein. (Q51773709) (← links)
- Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: role of the cholinergic system. (Q52170281) (← links)
- Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs. (Q52591788) (← links)
- Interleukin-15 protects from lethal apoptosis in vivo. (Q52998398) (← links)
- Immunoadhesins of interleukin-6 and the IL-6/soluble IL-6R fusion protein hyper-IL-6 (Q62658901) (← links)
- Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer (Q98735470) (← links)